14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $43.33 $52.87 Friday, 3rd May 2024 BMY stock ended at $43.99. This is 0.664% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 1.48% from a day low at $43.69 to a day high of $44.33.
90 days $43.33 $55.03
52 weeks $43.33 $69.10

Historical Bristol-Myers Squibb Company prices

Date Open High Low Close Volume
Jul 19, 2023 $62.12 $62.86 $62.00 $62.06 7 164 350
Jul 18, 2023 $61.94 $62.76 $61.80 $62.00 6 194 733
Jul 17, 2023 $61.99 $62.02 $61.41 $61.85 7 479 960
Jul 14, 2023 $62.02 $62.34 $61.57 $61.94 8 789 449
Jul 13, 2023 $62.40 $62.74 $62.21 $62.28 8 763 205
Jul 12, 2023 $62.88 $63.27 $62.12 $62.28 7 286 460
Jul 11, 2023 $62.32 $62.91 $62.12 $62.79 9 327 943
Jul 10, 2023 $62.63 $62.96 $62.30 $62.48 7 473 058
Jul 07, 2023 $63.24 $63.45 $62.63 $62.65 7 054 723
Jul 06, 2023 $63.66 $63.91 $63.30 $63.44 4 811 706
Jul 05, 2023 $64.31 $65.00 $63.92 $64.73 8 763 781
Jul 03, 2023 $63.94 $64.91 $63.44 $64.55 4 725 322
Jun 30, 2023 $64.28 $64.41 $63.94 $63.95 8 389 833
Jun 29, 2023 $63.77 $64.45 $63.63 $64.00 7 019 412
Jun 28, 2023 $64.70 $64.70 $62.88 $64.09 9 414 272
Jun 27, 2023 $64.75 $65.05 $64.22 $64.75 6 464 142
Jun 26, 2023 $65.04 $65.10 $64.01 $64.79 6 586 174
Jun 23, 2023 $65.38 $65.42 $64.89 $65.04 11 125 336
Jun 22, 2023 $65.75 $65.85 $65.12 $65.30 5 345 286
Jun 21, 2023 $65.91 $66.38 $65.45 $65.50 5 638 096
Jun 20, 2023 $65.83 $66.37 $65.25 $66.03 7 060 179
Jun 16, 2023 $64.88 $66.24 $64.61 $66.16 17 277 135
Jun 15, 2023 $64.24 $64.94 $63.87 $64.67 8 309 438
Jun 14, 2023 $64.76 $64.76 $64.76 $64.76 0
Jun 13, 2023 $64.19 $64.80 $63.96 $64.76 6 135 643
Click to get the best stock tips daily for free!

About Bristol-Myers Squibb Company

Bristol-Myers Squibb Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for th... BMY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT